These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6783374)

  • 1. Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
    Ward EA; Lang DA; Phillips MR; Turner RC
    Diabetes Care; 1981; 4(2):293-5. PubMed ID: 6783374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics.
    Haider Z; Obaidullah S; Fayyaz-ud-Din
    J Pak Med Assoc; 1976 Feb; 26(2):23-6. PubMed ID: 817043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
    Matthews DR; Cull CA; Stratton IM; Holman RR; Turner RC
    Diabet Med; 1998 Apr; 15(4):297-303. PubMed ID: 9585394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma insulin and glucose levels in diabetics treated with glibenclamide and chlorporpamide].
    Aiello C; Turner D; Aparicio NJ; De Turner EA; Vazquez A
    Acta Diabetol Lat; 1973; 10(1):30-53. PubMed ID: 4197367
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes.
    Ylitalo P; Oksala H; Pitkäjärvi T
    Arzneimittelforschung; 1985; 35(10):1596-9. PubMed ID: 3935120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics.
    Clarke BF; Campbell IW
    Lancet; 1975 Feb; 1(7901):246-8. PubMed ID: 8667857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.
    Shenfield GM; Logan A; Shirling D; Baird J
    Diabetologia; 1977 Aug; 13(4):367-71. PubMed ID: 913926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years.
    BMJ; 1995 Jan; 310(6972):83-8. PubMed ID: 7833731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorpropamide and glibenclamide serum concentrations in hospitalized patients.
    Huupponen R; Viikari J; Saarimaa H
    Ann Clin Res; 1982 Jun; 14(3):119-22. PubMed ID: 6814340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated blood glucose and plasma insulin levels in normal volunteer subjects receiving isocaloric meals, before and after chlorpropamide and glibenclamide.
    Owens DR; Seldrup J; Wragg KG; Shetty KJ; Biggs PI
    Horm Metab Res; 1977 Sep; 9(5):347-51. PubMed ID: 411723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P; Mughini L
    Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR; Biggs PI; Shetty KJ; Wragg KG
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of glibenclamide with chlorpropamide in newly diagnoeed maturity-onset diabetes.
    Gurling KJ
    Postgrad Med J; 1970 Dec; ():Suppl:66-9. PubMed ID: 5533301
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Treatment of maturity-onset diabetes.
    Clarke BF; Campbell IW
    Lancet; 1975 Mar; 1(7906):580-1. PubMed ID: 47059
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of long term sulfonylurea therapy on plasma insulin and fasting lipid levels.
    Podolsky S; Burney SW
    Diabete Metab; 1979 Jun; 5(2):113-7. PubMed ID: 478080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.
    Chu PC; Conway MJ; Krouse HA; Goodner CJ
    Ann Intern Med; 1968 Apr; 68(4):757-69. PubMed ID: 4868334
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Diabetologia; 1980 Jan; 18(1):17-22. PubMed ID: 6767639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glibenclamide--a better antidiabetic agent?].
    Blohmé G
    Lakartidningen; 1972 Dec; 69(52):6147-9. PubMed ID: 4631025
    [No Abstract]   [Full Text] [Related]  

  • 19. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 24-hour effects of glyburide and chlorpropamide after chronic treatment of type II diabetic patients.
    Prosser PR; Kosola JW; Bowers CY
    Am J Med Sci; 1985 May; 289(5):179-85. PubMed ID: 3923833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.